Our results underpin the importance of a reliable DM diagnosis by the clinician (pre-test probability) and suggest that the usefulness of anti-TIF1γ antibody detection depends not only on the method used but also on an accurate DM diagnosis. The gene discussed is TRIM33; the disease is dermatomyositis.